- Home
- IRON vs RSI Comparison
IRON vs RSI Comparison
Compare IRON & RSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IRON | RSI |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IRON | RSI |
|---|---|---|
| Price | $69.83 | $29.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 10 |
| Target Price | ★ $103.18 | $28.20 |
| AVG Volume (30 Days) | 384.6K | ★ 1.8M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 933.33 |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $1,134,428,000.00 |
| Revenue This Year | N/A | $25.44 |
| Revenue Next Year | $283.52 | $14.27 |
| P/E Ratio | ★ N/A | $376.50 |
| Revenue Growth | N/A | ★ 22.76 |
| 52 Week Low | $40.00 | $13.43 |
| 52 Week High | $99.50 | $30.14 |
Technical Indicators
Market Signals| Indicator | IRON | RSI |
|---|---|---|
| Relative Strength Index (RSI) | 54.12 | 63.98 |
| Support Level | $64.48 | $26.00 |
| Resistance Level | $71.85 | N/A |
| Average True Range (ATR) | 3.26 | 1.05 |
| MACD | 0.04 | 0.30 |
| Stochastic Oscillator | 64.61 | 73.02 |
Price Performance
Historical ComparisonAbout IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About RSI Rush Street Interactive Inc.
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.